Omar Kassim is a globally respected executive in pharmaceutical development and supply chain strategy, known for his leadership in CDMO partnership management, external manufacturing, and complex contract negotiations. With over two decades of experience spanning finance, procurement, and technical operations, he has guided multinational teams through end-to-end product development, from pre-clinical research to commercial launch. Currently leading Takeda’s Pharmaceutical Sciences CDMO organization, Omar drives strategic network design, vendor governance, and asset integration across 175 global partners. His deep expertise in combination products and drug delivery systems, coupled with a strong foundation in finance and biochemistry, positions him as a key architect of cross-functional success in today’s evolving life sciences landscape.

Michael A. Pereira is a seasoned regulatory and quality executive with over three decades of experience guiding companies through the complex intersection of FDA compliance, global regulatory standards, and business operations. Known for his ability to build and remediate Quality Management Systems across diverse healthcare sectors—including drug, device, biologic, and combination products—Michael has led strategic initiatives for startups and global enterprises alike. With a rare ability to bridge technical and business teams, he brings clarity, structure, and strategic foresight to every challenge, earning a reputation as a trusted leader and advisor in highly regulated industries.